The P3 Bavi trial got FDA fastback status so it appears the FDA thinks the early trials showed plenty of promise to help cancer patients.
Ken Dart and Blackrock see plenty of promise to own 5+% stakes in PPHM.
Rob Garnick got on board with PPHM due to the fantastic work of Dr. Philip Thorpe taking Bavi from the clinic and to the patients.
There are many very high profile KOL supporting the development of Bavi and 150+ cancer trial sites signed up and enrolling patients for the P3 Bavi lung trial going on 14 months now.
There has been a non stop battle of epic proportions to slow or stop Bavi development including trial sabotage. Yet we are still headed strongly to P3 results with Bavi already shown to double the SOC in a P2 second line lung cancer in a trial that was sabotaged and Bavi was strong enough to still show great results.
Bavi works so good a professional saboteur, a life long pharmacist couldn't make the results look bad.
There is now proof of a $2 billion dollar deal that was close to being signed with Abbvie and I expect the deal that finally is signed will be for more money and better terms now that Bavi is much more proven and understood.
I think PPHM and Bavi will be fine and those holding and working for PPHM will be greatly rewarded in due time.
Hopefully the real great aspect will be millions of cancer patients helped but this new novel drug with little to no bad side effects.
Market Data 
Markets 
AI
